Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. - Rembacken BJ; Snelling AM; Hawkey PM; Chalmers DM; Axon ATR; Rembacken, B J; Snelling, A M; Hawkey, P M; Chalmers, D M; Axon, A T (Lancet, 1999)